Digital Health Startups

Bot Image develops ProstatID, an AI-based software that analyzes prostate MRI scans to detect and highlight suspect lesions, helping urologists and radiologists improve diagnostic accuracy for prostate cancer. The tool supports clinical diagnosis and guides therapeutic decisions, often confirmed by biopsy.

0 investors

bQuest connects financial advisors with a vetted network of aging care, end-of-life, and after-loss specialists to help clients and families navigate care crises. The platform uses AI-powered guidance to support wealth management firms in serving aging populations.

0 investors

BrainsWay develops Deep TMS (Transcranial Magnetic Stimulation) systems for treating psychiatric and neurological conditions including depression, OCD, and smoking addiction. The platform includes brain-targeting stimulators with patented H-Coils, patient management capabilities, and clinical research-grade variants for healthcare providers.

0 investors

Burnalong offers a digital and local wellbeing platform with over 50,000 online classes across wellness categories taught by certified instructors, plus in-person access at local gyms. It serves employers, health plans, health systems, and schools to support employee and population health across physical, mental, financial, and chronic-condition wellness.

0 investors

C2N Diagnostics develops and commercializes blood-based diagnostic tests for Alzheimer's disease and other neurodegenerative conditions, using proprietary LC-MS/MS mass spectrometry to detect brain amyloid pathology. Its PrecivityAD, PrecivityAD2, and Precivity-ApoE tests serve health care professionals evaluating patients with cognitive impairment, available across all 50 US states and the District of Columbia.

0 investors

CAGE Bio is a clinical-stage biotech developing localized topical treatments for dermatology, inflammation, and immunology conditions using its proprietary deep eutectic ionic liquid platform. The technology enables small and large molecules such as proteins and nucleic acids to penetrate the skin, aiming to match the efficacy of systemic drugs while avoiding their side effects.

0 investors

CAIPA Foundation is a not-for-profit funded mainly by physician members of the Chinese-American IPA that runs community service and health awareness programs for Asian American communities through education, advocacy, and access to culturally and linguistically tailored medical services. It offers assistance under the Medicaid 1115 Waiver Program, connecting eligible members in the Greater New York area to food, housing, and community resources in Mandarin, Cantonese, and English.

0 investors

Cajal Therapeutics is a biotech company developing novel therapies through the translation of neuroscience research into therapeutic treatments for patients.

0 investors

A company building pharmacy infrastructure to support modern medicine, currently pre-launch. The page provides no further detail on its product or customers.

0 investors

Calm Waters AI provides autonomous evaluation and management (E/M) medical coding software that ingests medical records and assigns compliant E/M levels based on CMS guidelines, along with a complementary chart audit and physician training service called ChartPal. It serves physician groups, health systems, and hospitals to reduce coding time, improve chart accuracy, and lower audit and denial risk.

0 investors

Canary Speech develops vocal biomarker technology that analyzes voice to detect cognitive and behavioral conditions, providing clinicians, payers, and patients with decision-support signals on mood and cognitive status. Its API-first, HIPAA-compliant platform includes Canary Ambient, an ambient listening tool for preventive screening across healthcare settings, pharmaceutical trials, and call centers.

0 investors

Cardiff Lexington is a diversified healthcare holding company that acquires and operates businesses providing medical diagnostic and therapeutic services. It focuses on growth through strategic acquisitions of companies within the healthcare segment aimed at improving patient outcomes.

0 investors

Care3 offers a method to help families manage the clinical, social, and financial challenges of life-changing medical conditions. It positions itself in the digital health and care-support space for patients and their families.

0 investors

CaredFor is a HIPAA-compliant patient engagement platform for addiction and mental health treatment programs, offering tools such as secure messaging, peer support communities, surveys, telehealth, appointment reminders, and relapse indicators. It helps treatment facilities improve patient outcomes, increase admissions conversions, and reduce attrition across levels of care including alumni and family programming.

0 investors

CareDx provides innovative solutions and diagnostic tools for transplant patients throughout their pre- and post-transplant journey to improve outcomes and equity in organ transplantation.

0 investors

CareHarmony provides care coordination services aimed at improving patient care in the healthcare sector. Its focus is on scaling care coordination for patients.

0 investors

careMESH provides care coordination software including a managed provider directory, secure healthcare communications, and patient navigation and case management tools. It serves hospitals and health systems, health IT and technology providers, government health agencies and HIEs, and payers, using FHIR and HL7 standards-based integration.

0 investors

CellSolutions develops products for cytopathology sample preparation, cellular preservation and presentation, and digital automated screening with diagnostic interpretation. It serves clinical diagnostic applications, drawing on expertise in diagnostic cytopathology, clinical biochemistry, image analysis, and software engineering.

0 investors

Centrus Diagnostics develops CentrusDx Smart Bands, wearable sensor wristbands using photoplethysmography (PPG) to provide continuous, cuffless blood pressure and EKG measurements for patients, caregivers, and health-conscious consumers. The devices target the diagnosis and management of hypertension, heart failure, and atrial fibrillation, and are pending FDA 510(k) clearance in the U.S. and CDSCO approval in India.

0 investors

Cerora develops biosensor-based neurodiagnostic technology to provide objective, portable data for assessing brain function, with an initial focus on concussion and mild traumatic brain injury. Its tools are aimed at clinicians diagnosing concussions to support medical decisions and patient management.

0 investors

Certive Health is a health-related company with publicly filed financial documents accessible via SEDAR. The page provides only investor financial statements and MD&A filings, with no clear description of the company's specific products or services.

0 investors

Charlie Health is a virtual provider of high-acuity behavioral healthcare, delivering personalized, evidence-based treatment programs that combine licensed clinicians, peer connection, and family involvement. It serves individuals and families in the U.S. facing serious mental health and substance use challenges, with a focus on young people.

0 investors

Cirius Therapeutics is a clinical-stage pharmaceutical company developing therapies for patients with chronic metabolic diseases driven by insulin resistance, including Type 2 Diabetes and obesity.

0 investors

ClearNote Health develops DNA-based blood tests (the Avantect line for pancreatic, ovarian, and multi-cancer detection) aimed at detecting cancer at early stages in patients at elevated risk. It also offers Virtuoso, an epigenomics platform that measures disease biology and therapy response from a blood draw for drug discovery and development.

0 investors